局部晚期头颈鳞癌放化疗中胃造瘘管置入时机与临床结局探索
该回顾性研究分析144例接受根治性放化疗的局部晚期头颈鳞癌患者,按「预先置入」或「按需置入」胃造瘘管策略分组,用倾向评分加权探索置入时机相关因素与结局。预先置入更常见于女性、吞咽困难及接受诱导化疗者,并与化疗方案修改几率降低73%及输注门诊次数平均减少3次相关。
要点
- 预先胃造瘘置入与化疗方案修改几率降低73%相关(p=0.007)。
- 预先置入组输注门诊次数平均减少3次(p=0.038)。
- 放化疗时长、体重下降、急诊就诊、住院、ICU入住及生存无差异。
核心结论
- 胃造瘘管置入时机受多因素影响,预先置入与更少的化疗方案修改和输注门诊次数相关,需前瞻性验证。
研究设计与样本
- 回顾性分析144例2019至2024年接受根治性放化疗的局部晚期头颈鳞癌患者,按预先或按需胃造瘘策略分组,采用倾向评分加权。
主要发现
- 大多数患者为白人(85%)和男性(83%),中位年龄63岁。
- 预先胃造瘘置入60例(42%),在女性中更常见(64% vs 37%,p=0.015)。
- 预先置入在吞咽困难者中更常见(55% vs 28%,p=0.001),在接受诱导化疗者中也更常见(71% vs 38%,p=0.023)。
- 放化疗时长、体重下降、急诊就诊、住院、ICU入住及生存两组无差异。
- 预先置入与化疗方案修改几率降低73%相关(p=0.007),与输注门诊次数平均减少3次相关(p=0.038)。
临床怎么用
- 对女性、吞咽困难或接受诱导化疗的局部晚期头颈鳞癌放化疗患者,可考虑预先胃造瘘置入以减少化疗方案修改和输注门诊负担。
局限性
- 回顾性设计,样本量有限,结果需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: G-tube placement timing remains poorly characterized in patients with localized head and neck cancer (HNSCC) undergoing definitive chemoradiation (dCRT). METHODS: We retrospectively analyzed 144 patients with HNSCC who received dCRT (2019-2024), categorized by "upfront" or "as-needed" G-tube strategy, to explore factors associated with timing and outcomes using propensity score weighting. RESULTS: Most patients were White (85%) and male (83%); median age was 63 years. Upfront G-tube placement occurred in 60 patients (42%) and was more common among women (64% vs. 37%, p = 0.015) and those with dysphagia (55% vs. 28%, p = 0.001) or receiving induction chemotherapy (71% vs. 38%, p = 0.023). dCRT duration, weight loss, ED visits, hospitalizations, ICU admissions, and survival did not differ. Upfront placement was associated with lower odds of chemotherapy modification (73% lower, p = 0.007) and fewer infusion clinic visits (average 3 fewer, p = 0.038). CONCLUSION: These findings suggest multiple factors influence G-tube timing and outcomes, warranting prospective validation.
引用
- Chalker C, Burton JC, Kaempf A, et al. Exploring G-Tube Timing and Clinical Outcomes in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Chemoradiation. Head Neck. 2026. PMID: 42919669. doi:10.1002/hed.70518
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。